Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality
FDLI Enforcement and Litigation Conference, Jill Furman, Director Office of Compliance, CDER, December 2025
(WZTV) Tennessee lawmakers are moving forward with a rule change that would allow TennCare to cover FDA-approved weight-loss drugs for the treatment of obesity a shift supporters say could improve health outcomes for thousands of low-income residents, but one that critics warn could come with a high price tag
Across social media, women are crediting surprise pregnancies to their GLP-1 medication
Zepbound vs Semaglutide GLP-1 vs Wegovy
In this way, GLP-1 RAs exert cardiovascular and renal protective effects, improving nonalcoholic fatty liver disease through mechanisms including weight loss, blood glucose control, blood pressure reduction, lipid improvement, insulin resistance improvement, and inflammation and oxidative stress reduction [8]